CompanyOTCStony Brook, NY

Applied Dna Sciences INC

Applied DNA Sciences develops proprietary nucleic acid production solutions for biopharmaceutical and diagnostics applications.

SEC EDGAR ClinicalTrials.gov

8-KOct 1Latest SEC filing

Form DOct 15$58M sold

October 2026

BNB Plus Corp amends registration rights agreement with majority holders

Oct 1PartnershipApplied Dna Sciences INC

September 2026

BNB Plus Corp. board turns over, adds three directors tied to GlobalStake

Sep 3PeopleApplied Dna Sciences INC

August 2026

BNB Plus faces Nasdaq delisting determination, moves to OTCQB pending appeal

Aug 5FinancingApplied Dna Sciences INC

July 2026

BNB Plus Corp ends Cypress agreements, chairman to resign

Jul 29PartnershipApplied Dna Sciences INC

BNB Plus Corp amends registration rights agreement to push back filing deadline

Jul 2PartnershipApplied Dna Sciences INC